Our Pipeline
Our Pipeline
The Future of Medicine is Here:
Revolutionizing Exosome Science to Heal from Within!
At RION, we’re harnessing the power of platelet-derived exosomes, nature’s own delivery vehicles, to create the most advanced exosome clinical pipeline with PEP™
The Future of Medicine is Here:
Revolutionizing Exosome Science to Heal from Within!
At RION, we’re harnessing the power of platelet-derived exosomes, nature’s own delivery vehicles, to create the most advanced exosome clinical pipeline with PEP™
Expanded Access
Rion Inc. Policy on Expanded Access Program for IND 019567 for Wounds
Rion Inc. is dedicated to developing innovative treatments for serious and life-threatening conditions. Understanding that certain patients with serious or life-threatening diseases may have exhausted all available treatment options, meet the unique needs of expanded access requirements and are interested in receiving Rion’s drug candidate through an expanded access policy, Rion Inc. is willing to provide our investigational drug product PEP to patients for the treatment in compliance with FDA Expanded Access (Compassionate Use) Policies.